ArticleEClinicalMedicine2026

Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant non-small cell lung cancer (NEOTIDE/CTONG2104): phase II trial and correlative genomic analysis in China.

Chao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.